Schonfeld Strategic Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
+118,775
| New | +$2.42M | 0.02% | 804 |
|
|
2024
Q3 | – | Sell |
-119,629
| Closed | -$4.43M | – | 1926 |
|
|
2024
Q2 | $4.43M | Buy |
+119,629
| New | +$4.43M | 0.03% | 508 |
|
|
2024
Q1 | – | Sell |
-130,542
| Closed | -$5.18M | – | 1912 |
|
|
2023
Q4 | $5.18M | Buy |
+130,542
| New | +$5.18M | 0.03% | 459 |
|
|
2023
Q1 | – | Sell |
-14,266
| Closed | -$636K | – | 2078 |
|
|
2022
Q4 | $636K | Buy |
+14,266
| New | +$636K | 0.01% | 1386 |
|
|
2022
Q2 | – | Sell |
-14,100
| Closed | -$481K | – | 2504 |
|
|
2022
Q1 | $481K | Buy |
14,100
+457
| +3% | +$15.6K | ﹤0.01% | 1337 |
|
|
2021
Q4 | $527K | Sell |
13,643
-43,164
| -76% | -$1.67M | ﹤0.01% | 1168 |
|
|
2021
Q3 | $3.07M | Sell |
56,807
-20,073
| -26% | -$1.08M | 0.03% | 521 |
|
|
2021
Q2 | $2.57M | Buy |
76,880
+42,310
| +122% | +$1.41M | 0.03% | 605 |
|
|
2021
Q1 | $712K | Buy |
+34,570
| New | +$712K | 0.01% | 982 |
|